BioCentury | Apr 22, 2019
Distillery Therapeutics
Combined inhibition of EGFR and RAF1 for mutant-KRAS, mutant TP53-driven PDAC
...Ramon and Cajal Institute of Sanitary Research (IRYCIS), Madrid, Spain email: mcguerra@cnio.es CONTACT: Mariano Barbacid, same affiliation as above email: mbarbacid@cnio.es
Sandi Wong
Ramon and Cajal Institute of Sanitary Research
Spanish...
